Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2008/075906external-prioritypatent/WO2009036101A1/en
Application filed by Boston Biomedical, Inc.filedCriticalBoston Biomedical, Inc.
Publication of CY1123986T1publicationCriticalpatent/CY1123986T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Η παρούσα εφεύρεση αφορά τη σύνθεση και μεθόδους χρήσης αναστολέων του μονοπατιού Stat3 ή αναστολέων καρκινικών βλαστοκυττάρων σε συνδυαστική θεραπεία του καρκίνου.The present invention relates to the synthesis and methods of using inhibitors of the Stat3 pathway or inhibitors of cancer stem cells in combination therapy of cancer.
CY20211100258T2007-09-102021-03-24
NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
CY1123986T1
(en)